Delivery Order SPE2DX22D0010-SPE2D826FAT26
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Concerta ER Tabs 36mg with a ceiling value of $62,578.41. This firm fixed-price, non-set-aside contract is scheduled for completion by September 9, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Concerta ER Tablets 36mg with a ceiling value of $15,818.06. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle and involves no set-aside designation. The award was made competitively and will be performed at the...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $28,591.14 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Concerta ER Tablets 36mg. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract requires completion by July 28, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Concerta ER 36 mg tablets (100-count packaging) valued at $2,786.94. This firm fixed-price delivery order, which was competitively awarded without set-aside designation, is scheduled for completion by July 30, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply...
- On September 16, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $23,558.87 to AmerisourceBergen Drug Corp for the supply of Concerta ER (extended-release) 36 mg tablets. This competitive, firm fixed-price delivery order, which carries no set-aside designation, is scheduled for completion by September 17, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Concerta ER Tablets 36mg with a ceiling value of $19,082.45. This firm fixed-price delivery order, which is expected to be completed by August 22, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Concerta ER 36 mg tablets in quantities of 100 units. This is a firm fixed-price delivery order with a ceiling value of $3,836.73 and an ultimate completion date of July 15, 2025. The contract was competitively awarded with no set-aside designation, and performance will take place at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Concerta 36mg tablets (100-count units) with a ceiling value of $14,003.58. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by October 15, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $27,314.50 for 100 tablets of Concerta ER 54 mg on August 15, 2025, with completion scheduled for August 18, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Concerta ER 36 mg tablets in quantities of 100 units, with a contract ceiling value of $8,445.43. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The ultimate completion date is set for October 24, 2025, and performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FAT26Delivery Order
The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Concerta ER Tabs 36mg pharmaceutical products. This firm fixed-price delivery order, valued at $20,665.92, is scheduled for completion by October 31, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The award was made on a competitive basis without any set-aside designation, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement requirements. This delivery order represents a task order under AmerisourceBergen Drug Corp's significant Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a prime pharmaceutical vendor for the Defense Logistics Agency, AmerisourceBergen supplies a comprehensive range of medications and medical commodities to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The company's extensive federal contract portfolio demonstrates consistent delivery of both brand-name and generic pharmaceuticals across multiple therapeutic domains through firm fixed-price delivery orders.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.7k | 10/30/25 |